New vaccine uses your own cancer cells to fight recurrence
Disease control
Not yet recruiting
This study tests a personalized immunotherapy called OncoVax for people with stage II colon cancer. After surgery to remove the tumor, patients receive a vaccine made from their own cancer cells to train the immune system to prevent the cancer from coming back. The trial involves…
Phase: PHASE3 • Sponsor: Vaccinogen Inc • Aim: Disease control
Last updated May 17, 2026 16:27 UTC